Compression Therapy Market

Key Players: Companies such as Essity (SE), Medi (DE), Sigvaris (CH), BSN medical (DE), 3M (US), Juzo (DE), Lohmann & Rauscher (DE), Tactile Medical (US), Kangaroo (US) are some of the major participants in the global market.

Compression Therapy Market

Compression Therapy Market Research Report: Size, Share, Trend Analysis By Product Type (Compression Garments, Compression Bandages, Compression Pumps, Compression Hosiery), By Applications (Chronic Venous Insufficiency, Lymphedema, Sports Injuries, Post-Surgical Recovery), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Rehabilitation Centers), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Medical Supply Stores) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
ID: MRFR/Pharma/5719-HCR
90 Pages
Rahul Gotadki
Last Updated: June 19, 2026
Request Free Sample

Compression Therapy Market Summary

Global Compression Therapy Market Size was valued at USD 3,900.55 Million in 2024 & the market is projected to grow from USD 4,111.97 Million in 2025 to USD 6,970.91 Million by 2035, registering a CAGR of 5.42% during the forecast period 2025–2035. North America led the market with over 49.99% share, generating around USD 1,950 Million in revenue.
 
The rising prevalence of chronic venous disorders, lymphedema, and edema is a major growth driver for the Compression Therapy Market. Increasing awareness of early intervention, coupled with growing adoption of non-invasive treatment approaches, is accelerating demand for advanced compression therapy products globally.
 
According to the WHO, the global population aged 60 years and older is expected to reach 2.1 billion by 2050, significantly increasing the number of individuals susceptible to venous and lymphatic disorders that commonly require compression therapy management.

Key Market Trends & Highlights

The Compression Therapy Market is experiencing robust growth driven by technological advancements and increasing awareness of chronic conditions.

  • North America accounted for over 49.99% of global Compression Therapy Market revenue in 2024, retaining regional leadership.
  • Europe generated USD 1.20 billion in revenue during 2024, representing approximately 30.76% of the global market.
  • Lymphedema Management accounted for approximately 36% of market revenue in 2024, maintaining leadership among application segments globally.
  • Compression Garments captured nearly 48% of total market revenue in 2024, driven by comfort, effectiveness, and broad clinical adoption.
  • Hospitals represented approximately 51% of end-user revenue in 2024, reflecting strong utilization in chronic venous disorder management.
  • Online Retail generated around 44% of distribution channel revenue in 2024, supported by expanding healthcare e-commerce adoption.

Market Size & Forecast

2024 Market Size 3900.55 (USD Million)
2035 Market Size 6970.91 (USD Million)
CAGR (2025 - 2035) 5.42%

Major Players

Companies such as Essity (SE), Medi (DE), Sigvaris (CH), BSN medical (DE), 3M (US), Juzo (DE), Lohmann & Rauscher (DE), Tactile Medical (US), Kangaroo (US) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Compression Therapy Market Trends

The Compression Therapy Market is currently experiencing a notable evolution, driven by a confluence of factors that appear to enhance its growth trajectory. Increasing awareness regarding the benefits of compression therapy in managing various medical conditions, such as venous disorders and lymphedema, seems to be a primary catalyst. 

Additionally, advancements in technology and product innovation are likely to play a pivotal role in shaping the market landscape. Manufacturers are focusing on developing more effective and user-friendly devices, which may lead to greater adoption among healthcare professionals and patients alike. 

Furthermore, the rising geriatric population, which often requires specialized care, could further bolster demand for compression therapy solutions. The market appears to be influenced by a growing emphasis on preventive healthcare. As individuals become more proactive about their health, the utilization of compression therapy for preventive measures is likely to gain traction. This shift in focus may encourage healthcare providers to incorporate compression therapy into standard treatment protocols. 

Additionally, the expansion of distribution channels, including online platforms, is expected to enhance accessibility for consumers. Overall, the Compression Therapy Market is poised for continued growth, driven by a combination of technological advancements, increased awareness, and evolving healthcare practices.

Technological Advancements

Recent innovations in materials and design are enhancing the functionality of compression garments. These advancements may lead to improved comfort and effectiveness, making products more appealing to consumers.

  • Essity continues investing in product development and innovation while expanding strategic partnerships and collaborations across wound care and compression therapy solutions. The company reported annual sales exceeding SEK 146 billion in 2024, supporting continuous innovation in advanced compression materials. Improved garment comfort, breathability, and therapeutic effectiveness are strengthening patient adherence and accelerating adoption of next-generation compression therapy products.

Increased Awareness

There is a growing recognition of the health benefits associated with compression therapy. This heightened awareness is likely driving demand among both healthcare professionals and patients.

  • Medi continues strengthening its portfolio through acquisitions, portfolio expansion initiatives, and ongoing regulatory advancements. The company operates in more than 90 countries, enhancing global access to compression solutions. Rising awareness among healthcare professionals regarding the clinical benefits of compression therapy for venous disorders, lymphedema, and edema management is contributing to increased treatment adoption and market expansion.

Demographic Shifts

The aging population is contributing to a rise in conditions that require compression therapy. As the demographic landscape evolves, the market may see increased demand for related products.

  • Sigvaris continues advancing product development and innovation supported by regulatory compliance and clinical validation initiatives. With products distributed across more than 70 countries, the company remains a prominent participant in compression therapy. The expanding elderly population and increasing prevalence of chronic venous insufficiency are creating sustained demand for compression garments and related therapeutic solutions worldwide.

Compression Therapy Market Drivers

Market Growth Projections

The Global Compression Therapy Market is projected to experience substantial growth over the next decade. With a market value of 3.48 USD Billion in 2024, it is expected to reach approximately 5.6 USD Billion by 2035. 
 
This growth trajectory suggests a compound annual growth rate of 4.42% from 2025 to 2035. Factors contributing to this growth include the rising prevalence of chronic venous disorders, technological advancements in compression devices, and an increasing geriatric population. These dynamics indicate a robust and expanding market, reflecting the growing importance of compression therapy in healthcare.

  • According to IHME, chronic venous disease and lower-extremity vascular disorders continue to contribute significantly to global disability and healthcare utilization, supporting long-term demand for compression therapy products.

Increasing Geriatric Population

The aging global population is a significant driver of the Global Compression Therapy Market. Older adults are more susceptible to conditions requiring compression therapy, such as edema and venous insufficiency. As the demographic shift continues, healthcare systems worldwide are adapting to meet the needs of this population. 
 
The increasing demand for compression therapy solutions tailored for older patients is likely to stimulate market growth. This trend aligns with the projected compound annual growth rate of 4.42% from 2025 to 2035, indicating a sustained increase in market value as the geriatric population expands.

  • According to the World Bank, the global population aged 65 years and above exceeded 800 million people, creating a large patient pool susceptible to venous insufficiency, edema, and lymphedema.

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure, particularly in developing regions, is a critical driver for the Global Compression Therapy Market. Improved access to healthcare facilities and services is facilitating the diagnosis and treatment of conditions that benefit from compression therapy. 
 
As healthcare systems evolve and invest in advanced medical technologies, the availability of compression therapy products is likely to increase. This trend is expected to support the market's growth trajectory, aligning with the anticipated compound annual growth rate of 4.42% from 2025 to 2035, as more patients gain access to necessary treatments.

  • World Bank data indicate that healthcare expenditure continues to rise globally, improving access to diagnosis, treatment facilities, and advanced therapeutic solutions including compression therapy.

Growing Awareness of Preventive Healthcare

There is a notable increase in awareness regarding preventive healthcare measures, which is positively influencing the Global Compression Therapy Market. Patients and healthcare providers are increasingly recognizing the benefits of compression therapy not only for treating existing conditions but also for preventing complications related to venous disorders. 
 
Educational initiatives and campaigns aimed at promoting the importance of early intervention are likely to enhance market penetration. This growing awareness is expected to contribute to the market's expansion, supporting the forecasted growth from 3.48 USD Billion in 2024 to 5.6 USD Billion by 2035.

  • PubMed studies demonstrate that early compression therapy intervention can reduce complications associated with chronic venous disorders, supporting broader adoption of preventive treatment strategies.

Rising Prevalence of Chronic Venous Disorders

The Global Compression Therapy Market is experiencing growth due to the increasing prevalence of chronic venous disorders such as varicose veins and chronic venous insufficiency. These conditions affect millions globally, leading to a heightened demand for effective treatment options. 
 
Compression therapy is recognized as a primary intervention for managing these disorders, which is likely to drive market expansion. As of 2024, the market is valued at approximately 3.48 USD Billion, and this figure is expected to rise significantly as awareness and diagnosis of venous disorders improve, indicating a robust growth trajectory for the industry.

  • According to PubMed, chronic venous disease affects up to 25% of adults globally, highlighting substantial demand for compression therapy as a first-line treatment approach.

Technological Advancements in Compression Devices

Technological innovations in compression therapy devices are propelling the Global Compression Therapy Market forward. Enhanced features such as programmable pressure settings, smart textiles, and wearable technology are making compression therapy more effective and user-friendly. 
 
These advancements not only improve patient compliance but also expand the range of applications for compression therapy, including post-surgical recovery and sports medicine. As the industry evolves, the integration of technology is likely to attract a broader consumer base, contributing to the projected market growth from 3.48 USD Billion in 2024 to an estimated 5.6 USD Billion by 2035.

  • PubMed research highlights that advanced pneumatic compression systems significantly improve edema management outcomes and patient adherence through customizable pressure delivery technologies.

Market Segment Insights

By Application: Lymphedema Management (Largest) vs. Athletic Recovery (Fastest-Growing)

Lymphedema management holds the largest share in the compression therapy market at 36% among the application segments, followed closely by venous ulcer treatment and deep vein thrombosis prevention. Post-Surgical Recovery and Athletic Recovery are also significant segments, but they represent smaller portions of the overall market. The diverse range of conditions treated by compression therapy ensures a balanced distribution, with Lymphedema Management dominating due to the rising awareness of lymphatic disorders. The growth trends in this market segment are primarily driven by an increasing incidence of lymphedema and chronic venous disorders, coupled with a growing aging population. Moreover, advancements in healing technologies and greater awareness surrounding the benefits of compression therapy are contributing to the rapid growth of segments like Athletic Recovery, making it one of the fastest-growing applications in this market.

Essity continues expanding its healthcare portfolio through innovative wound care and compression solutions. Lymphedema Management accounted for approximately 36% of Compression Therapy Market revenue in 2024, reflecting increasing diagnosis rates and greater awareness regarding long-term lymphatic disorder management.

By Product Type: Compression Garments (Largest) vs. Compression Pumps (Fastest-Growing)

The segment distribution reveals that compression garments hold the largest share in the compression therapy market at 48%, due to their widespread acceptance and effectiveness in managing conditions such as lymphedema and post-surgery recovery. They dominate the market due to their comfortable wear and versatility, making them a preferred choice among healthcare providers and patients alike. On the other hand, Compression Pumps are identified as the fastest-growing segment, driven by advancements in technology and increasing awareness of the benefits of pneumatic compression therapy. Their ability to provide effective treatment for chronic venous insufficiency is boosting their adoption in both clinical and home settings, thus propelling market growth in this category.

Medi continues strengthening its compression therapy portfolio through product innovation and clinical support programs. Compression Garments represented approximately 48% of market revenue in 2024, supported by their effectiveness, comfort, and widespread adoption across healthcare settings.

By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the Compression Therapy Market, hospitals constitute the largest share of the end-user segment, accounting for 51%, significantly outpacing other settings due to their comprehensive medical infrastructure and higher patient volumes. Clinics and rehabilitation centers also play vital roles, but they hold smaller market shares compared to hospitals. Home care settings are gaining traction, driven by the increasing preference for at-home treatments and patient convenience, which positions them as emerging players in this space.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals lead the market, featuring advanced facilities and a wide array of therapeutic options, catering to a large volume of patients requiring specialized compression therapy. Their robust infrastructure enables the provision of tailored treatment plans, making them a dominant force. In contrast, home care settings represent an emerging segment, driven by the aging population and growing health consciousness among patients. They provide flexibility, comfort, and cost-effectiveness, as patients increasingly opt for home-based solutions rather than traditional hospital visits. This shift demonstrates the evolving landscape of healthcare, where convenience and personalized care are becoming paramount.

By Distribution Channel: Online Retail (Largest) vs. Pharmacies (Fastest-Growing)

The Compression Therapy Market demonstrates varied distribution across different channels, with online retail claiming the largest share at 44%. It has transformed the way consumers access compression therapy products, driven by the convenience of online shopping and the growing preference for e-commerce over traditional outlets. Pharmacies, on the other hand, represent a rapidly expanding segment, taking advantage of established healthcare infrastructure and convenient access for consumers seeking immediate solutions.

Online Retail (Dominant) vs. Medical Supply Stores (Emerging)

Online retail stands out as the dominant distribution channel for compression therapy products. It caters to a tech-savvy demographic looking for ease of purchase and greater variety. Medical supply stores are emerging as a significant player, targeting consumers who value specialized products and expert advice. While the online market thrives on convenience, medical supply stores leverage personalized customer service and product knowledge. Together, these channels offer complementary strengths in meeting consumer needs. The rise of telemedicine and increased health awareness are driving both segments, creating a robust marketplace for compression therapy solutions.

Get more detailed insights about Compression Therapy Market
Request Free Sample

Regional Insights

North America : Market Leader in Compression Therapy

North America leads in the Compression Therapy Market size, accounting for over 49.99% of the global revenue in 2024. The growth is driven by an increasing prevalence of chronic venous diseases and a rising aging population. Regulatory support, including reimbursement policies for compression therapy products, further fuels demand. 

  • According to CDC data, approximately 900,000 Americans are affected by deep vein thrombosis and pulmonary embolism annually, supporting sustained demand for compression therapy products used in prevention and post-treatment care.

The United States stands out as the leading country, with major players like 3M and Essity driving innovation and competition. The presence of established companies ensures a robust supply chain and product availability. The availability of a biotech job in USA hubs like Boston and San Francisco is increasingly tied to expertise in next-generation modalities, such as antibody-drug conjugates and cell therapies.

  • GE HealthCare invested approximately USD 1 billion annually in research and development, supporting advancements in healthcare technologies, vascular diagnostics, and patient management systems that facilitate compression therapy utilization.

Additionally, the market is characterized by strategic partnerships and collaborations among key players, enhancing product offerings and market reach. This competitive landscape positions North America as a hub for compression therapy advancements.

Europe : Emerging Market with Growth Potential

Europe Compression Therapy Market size was valued at USD 1200 million in 2024, making it the second-largest regional market with a 30.76% share, reflecting a growing demand driven by an increase in lifestyle-related health issues and an aging population. Regulatory frameworks in the EU promote high standards for medical devices, ensuring safety and efficacy. The market is also supported by initiatives aimed at improving healthcare access and affordability, which are crucial for expanding the reach of compression therapy solutions across diverse demographics.

  • According to EMA regulatory data, the agency continues overseeing the safety and effectiveness of thousands of medical products across Europe, supporting broader access to advanced therapeutic solutions. Strong regulatory oversight and healthcare infrastructure contribute to growing adoption of compression therapy products throughout major European markets.

Leading countries in this region include Germany, France, and the UK, where established healthcare systems facilitate the adoption of advanced compression products. Key players like Medi and Sigvaris are actively innovating to meet the evolving needs of patients. The competitive landscape is characterized by a mix of local and international companies, fostering a dynamic environment for growth and collaboration. "The European market is witnessing a significant shift towards preventive healthcare solutions, including compression therapy," European Commission report, European Commission.

Asia-Pacific : Rapidly Growing Market Opportunities

The Asia-Pacific region, with a market size of $1200.0M, is experiencing rapid growth in the Compression Therapy Market. This surge is attributed to increasing healthcare expenditures, rising awareness of chronic diseases, and a growing elderly population. Governments are implementing policies to enhance healthcare infrastructure, which is crucial for the distribution and accessibility of compression therapy products. The region's diverse demographics also present unique opportunities for tailored solutions.

Countries like China, Japan, and India are leading the charge, with significant investments in healthcare technology and innovation. The competitive landscape features both established players and emerging companies, creating a vibrant market. Key players such as Lohmann & Rauscher and Juzo are expanding their presence, focusing on product development and strategic partnerships to capture market share. The region's potential for growth is immense, driven by a combination of economic development and increasing health awareness.

Middle East and Africa : Untapped Market with Growth Potential

The Middle East & Africa Compression Therapy Market, valued at $550.55M, is still in its nascent stages but shows promising growth potential. Factors such as increasing healthcare investments and a rising prevalence of chronic diseases are driving demand for compression therapy solutions. Regulatory bodies are beginning to establish frameworks that support the introduction of innovative medical devices, which is essential for market growth. The region's diverse healthcare needs also create opportunities for customized solutions.

Leading countries in this region include South Africa and the UAE, where healthcare infrastructure is improving. The competitive landscape is characterized by a mix of local and international players, with companies like BSN Medical and Kangaroo making significant inroads. As awareness of the benefits of compression therapy grows, the market is expected to expand, driven by both public and private sector initiatives. "The healthcare sector in the Middle East is evolving rapidly, with a focus on enhancing patient care through innovative solutions," World Health Organization report, World Health Organization.

Compression Therapy Market Regional Image

Key Players and Competitive Insights

The Compression Therapy Market is currently characterized by a dynamic competitive landscape, driven by increasing awareness of chronic venous diseases and the growing prevalence of conditions requiring compression therapy. Leading manufacturers are prioritizing ergonomic designs in legs compression wear to ensure consistent pressure application while improving patient compliance through enhanced material breathability.
 
Companies like Compression Therapy Services Inc. are dominating the  post-acute care space, plays a vital role in coordinating long-term lymphedema management between physicians and home-care settings. On the other hand, to differentiate themselves from Tactile Medical competitors, many firms are investing heavily in clinical trials to prove the superior efficacy of their proprietary sequential gradient patterns.
 
Key players such as Essity (SE), Medi (DE), and 3M (US) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Essity (SE) focuses on sustainability and product innovation, while Medi (DE) emphasizes technological advancements in their product offerings. 3M (US) is known for its robust supply chain and strategic partnerships, which collectively shape a competitive environment that is increasingly focused on quality and efficacy.
 
The market structure appears moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. This fragmentation allows for a diverse range of products and solutions, catering to various consumer needs. The collective influence of these key players fosters a competitive atmosphere where innovation and customer-centric strategies are paramount.
 
In November 2025, Medi (DE) announced the launch of a new line of smart compression garments that integrate wearable technology to monitor patient compliance and provide real-time feedback. This strategic move not only enhances patient engagement but also positions Medi (DE) as a leader in the integration of technology within compression therapy, potentially setting a new standard in the industry.
 
In October 2025, 3M (US) expanded its manufacturing capabilities in Europe by investing €10 million in a new facility dedicated to producing advanced compression therapy products. This expansion is significant as it not only increases production capacity but also reduces lead times, thereby enhancing supply chain reliability and responsiveness to market demands.
 
In September 2025, Essity (SE) entered into a strategic partnership with a leading telehealth provider to offer integrated solutions for patients requiring compression therapy. This collaboration is indicative of a broader trend towards digital health solutions, allowing for improved patient monitoring and adherence to treatment protocols, which could lead to better health outcomes and increased customer loyalty.
 
As of December 2025, the Compression Therapy Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology integration, and supply chain reliability, reflecting a shift towards more sophisticated and patient-centered solutions.

Key Companies in the Compression Therapy Market include

Industry Developments

Recent developments in the Compression Therapy Market have seen significant growth, driven by increasing awareness of chronic conditions such as diabetes and venous diseases. The competitive landscape for biocomputing companies is shifting toward those that can offer integrated platforms combining hardware-accelerated processing with proprietary AI-driven genomic analysis. 

Companies like Cardinal Health, Essity, and BSN Medical are expanding their product offerings to cater to the rising demand for effective compression solutions. In July 2023, DJO Global launched an advanced line of pneumatic compression devices aimed at enhancing recovery outcomes for patients post-surgery.

Additionally, in August 2023, Smith and Nephew acquired a technology company that specializes in innovative wound care solutions, thus enhancing their compression therapy portfolio. Current affairs indicate a focus on integrating technology in compression products; for example, Medtronic's recent investment in connected health solutions aims to improve patient compliance and reporting.

Furthermore, the market demonstrates a healthy competitive landscape, with continuous product innovations and strategic partnerships. The growth potential is further underscored by the increasing prevalence of lifestyle diseases globally, compelling manufacturers to invest in Research and Development. Notably, the regulatory environments in countries are becoming more favorable, promoting the adoption and reimbursement policies for compression therapies that aid in better patient management.

Future Outlook

Compression Therapy Market Future Outlook

The Compression Therapy Market size is projected to reach USD 6970.91 Million by 2035, growing at a CAGR of 5.42%, driven by increasing awareness of chronic venous diseases and advancements in technology.

New opportunities lie in:

  • Expansion of telehealth services for remote patient monitoring Development of customizable compression garments for niche markets Partnerships with healthcare providers for integrated care solutions

By 2035, the Compression Therapy Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Compression Therapy Market End User Outlook

  • Hospitals
  • Clinics
  • Home Care Settings
  • Rehabilitation Centers
  • Athletic Facilities

Compression Therapy Market Application Outlook

  • Lymphedema Management
  • Venous Ulcer Treatment
  • Deep Vein Thrombosis Prevention
  • Post-Surgical Recovery
  • Athletic Recovery

Compression Therapy Market Product Type Outlook

  • Compression Garments
  • Compression Bandages
  • Compression Pumps
  • Compression Stockings
  • Compression Sleeves

Compression Therapy Market Distribution Channel Outlook

  • Online Retail
  • Pharmacies
  • Medical Supply Stores
  • Direct Sales
  • Hospitals

Report Scope

MARKET SIZE 2024 3900.55(USD Million)
MARKET SIZE 2025 4111.97(USD Million)
MARKET SIZE 2035 6970.91(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.42% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Essity (SE), Medi (DE), Sigvaris (CH), BSN medical (DE), 3M (US), Juzo (DE), Lohmann & Rauscher (DE), Tactile Medical (US), Kangaroo (US)
Segments Covered Application, Product Type, End User, Distribution Channel
Key Market Opportunities Integration of smart technology in the market enhances patient compliance and treatment efficacy.
Key Market Dynamics Rising demand for innovative compression therapy solutions drives competitive dynamics and regulatory adaptations in the market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Compression Therapy Market?

As of 2024, the Compression Therapy Market was valued at approximately 3900.55 USD Million.

What is the projected market size for the Compression Therapy Market by 2035?

The market is expected to reach a valuation of around 6970.91 USD Million by 2035.

What is the expected CAGR for the market during the forecast period?

The anticipated CAGR for the market from 2025 to 2035 is 5.42%.

Which application segment had the highest valuation in 2024?

In 2024, the Venous Ulcer Treatment segment was valued at 950.0 USD Million, making it the highest among application segments.

What are the projected values for Lymphedema Management by 2035?

The Lymphedema Management segment is projected to reach approximately 1390.0 USD Million by 2035.

Which product type is expected to show significant growth in the Compression Therapy Market?

Compression Stockings, valued at 800.0 USD Million in 2024, are expected to grow to around 1500.0 USD Million by 2035.

What is the market valuation for Home Care Settings in 2024?

In 2024, the Home Care Settings segment was valued at 780.11 USD Million.

Which key players are leading the Compression Therapy Market?

Key players in the market include Essity, Medi, BSN medical, 3M, and Sigvaris, among others.

What is the projected market value for Compression Bandages by 2035?

The Compression Bandages segment is expected to reach approximately 1100.0 USD Million by 2035.

How does the market for Athletic Recovery compare to other segments?

The Athletic Recovery segment was valued at 699.0 USD Million in 2024 and is projected to grow to about 1180.0 USD Million by 2035.

Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations specific to vascular medicine, lymphology, and wound care management. Key sources included the US Food & Drug Administration (FDA) 510(k) Premarket Notification Database and Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA) Medical Device Regulation (MDR) classifications, Health Canada Medical Devices Bureau, Therapeutic Goods Administration (TGA) Australia, and Pharmaceuticals and Medical Devices Agency (PMDA) Japan. Clinical and epidemiological data were gathered from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), Centers for Disease Control and Prevention (CDC) Chronic Disease Indicators, National Lymphedema Network (lymphnet.org), American Vein & Lymphatic Society (AVLS), Society for Vascular Surgery (SVS), International Lymphoedema Framework, Wound Ostomy and Continence Nurses Society (WOCN), and European Wound Management Association (EWMA). Reimbursement and health economics data were sourced from the Centers for Medicare & Medicaid Services (CMS) Local Coverage Determinations (LCDs) for compression therapy, Medicare Durable Medical Equipment (DME) fee schedules, Eurostat Healthcare Database, NHS England Prescribing Data, and WHO Global Health Observatory. Disease prevalence statistics were obtained from the International Union of Phlebology (UIP), American College of Phlebology, National Center for Health Statistics (NCHS) National Health Interview Survey, and peer-reviewed journals including Phlebology, Journal of Vascular Surgery: Venous and Lymphatic Disorders, Lymphatic Research and Biology, and Wound Repair and Regeneration. These sources facilitated collection of procedure volumes for chronic venous disease treatments, lymphedema incidence rates, regulatory approval pathways for compression devices, clinical efficacy studies comparing static vs. dynamic compression, and competitive landscape analysis for compression garment manufacturers and pneumatic compression device developers.

 

Primary Research

In order to gain quantitative and qualitative insights that are unique to the compression therapy ecosystem, the primary research process involved interviewing players from both the supply and demand sides. Members of the supply side that participated in the study included the chief executive officers, vice presidents of product development, heads of regulatory affairs, and commercial directors from companies that make compression garments, pneumatic compression pumps, medical hosiery, compression bandages, and other similar products. Certified lymphedema therapists (CLTs), wound care specialists, physiotherapists, board-certified vascular surgeons, phlebologists, medical directors of lymphedema clinics, purchasing managers from home medical equipment (HME) distributors, administrators of rehabilitation centers, and others made up the demand-side sources. Primary research has proven the validity of market segmentation based on static and dynamic compression modalities, verified the timelines for smart compression garments with sensors, and uncovered insights into the pricing strategies for custom-fitted vs. off-the-shelf garments, reimbursement dynamics for pneumatic compression devices versus compression stockings, and clinical adoption patterns between hospitals and home care settings.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (33%), Others (35%)

By Region: North America (38%), Europe (30%), Asia-Pacific (22%), Rest of World (10%)

 

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis specific to compression therapy devices and garments. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa specializing in compression pumps, gradient compression garments, anti-embolism stockings, and short-stretch compression bandages

Product mapping across static compression (garments, bandages, hosiery) and dynamic compression (intermittent pneumatic compression pumps, lymphedema pumps) categories, with further segmentation by compression levels (Class I: 20-30 mmHg, Class II: 30-40 mmHg, Class III: >40 mmHg)

Analysis of reported and modeled annual revenues specific to compression therapy portfolios, including private company revenue estimates derived from Medicare DME billing data and hospital procurement records

Coverage of manufacturers representing approximately 72-77% of global market share in 2024, encompassing dominant players in medical compression hosiery and pneumatic compression devices

Extrapolation using bottom-up (procedure volume × ASP by country for lymphedema treatments, chronic venous insufficiency management, DVT prophylaxis, and venous ulcer care) and top-down (manufacturer revenue validation across textile-based and mechanical compression segments) approaches to derive segment-specific valuations for hospital, ambulatory surgical center, and home care settings

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.